Home › Funds › Illumine Investment Management, LLC › LMAT
Illumine Investment Management, LLC position in LMAT
LEMAITRE VASCULAR INC COM · Health Care
Illumine Investment Management, LLC reported holding 14,874 shares of LMAT (LEMAITRE VASCULAR INC COM) in its Q1 2026 13F filing — a position valued at US$1.6M, representing 1.25% of its reported portfolio and ranking #26 among its reported holdings. Illumine Investment Management, LLC has disclosed LMAT holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Illumine Investment Management, LLC's LMAT position evolved
Illumine Investment Management, LLC first disclosed a stake in LMAT in Q4 2024 at 13,432 shares (US$1.2M). The position peaked in Q1 2026 at 14,874 shares, worth US$1.6M. Across 6 filings, Illumine Investment Management, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 14,874 shares valued at US$1.6M — an increase of 538 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 13.43K | $1.24M | New |
| Q1 2025 | 13.52K | $1.13M | Add |
| Q2 2025 | 13.84K | $1.15M | Add |
| Q3 2025 | 14.03K | $1.23M | Add |
| Q4 2025 | 14.34K | $1.16M | Add |
| Q1 2026 | 14.87K | $1.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LMAT and 13F data
LMAT (LEMAITRE VASCULAR INC COM) is a Health Care company. 40 other funds we track also report a position in LMAT — the largest reported positions include Conestoga Capital Advisors, LLC (US$131.2M), Copeland Capital Management, LLC (US$76.3M), GENEVA CAPITAL MANAGEMENT LLC (US$56.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LMAT
- Conestoga Capital Advisors, LLC 1.37M sh · $131.23M · Q2 2026
- Copeland Capital Management, LLC 924.08K sh · $76.32M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 589.06K sh · $56.53M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 20.00M sh · $21.26M · Q2 2026
- Ranger Investment Management, L.P. 219.31K sh · $21.04M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 189.91K sh · $18.22M · Q2 2026
- Grandeur Peak Global Advisors, LLC 161.01K sh · $15.45M · Q2 2026
More on Illumine Investment Management, LLC
FAQ
How long has Illumine Investment Management, LLC held LMAT?
Illumine Investment Management, LLC has disclosed LMAT holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is Illumine Investment Management, LLC's current position in LMAT?
As of Q1 2026, Illumine Investment Management, LLC holds 14.87K shares of LMAT (LEMAITRE VASCULAR INC COM), valued at $1.62M, representing 1.25% of its reported portfolio and ranking #26.
Has Illumine Investment Management, LLC been buying or selling LMAT?
In the latest 13F filing (Q1 2026), Illumine Investment Management, LLC increased its position in LMAT. The position peaked in Q1 2026 at 14.87K shares.
Which other funds hold LMAT?
Other major institutional holders of LMAT include Conestoga Capital Advisors, LLC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.